InvestorsHub Logo

Esa

Followers 11
Posts 419
Boards Moderated 0
Alias Born 02/21/2011

Esa

Re: None

Wednesday, 12/04/2019 2:41:56 PM

Wednesday, December 04, 2019 2:41:56 PM

Post# of 3740
Thursday, December 5
6.00 p.m LB7 - One-month oral treatment with PTI-125, a new drug candidate, reduces CSF and plasma biomarkers of Alzheimer’s disease
Lindsay BURNS (1), Hoau-Yan WANG (2), Zhe PEI (2), Kuo-Chieh LEE (2), Carrie CROWLEY (2), Michael MARSMAN (2),
Nadav FRIEDMANN (2)
(1) Cassava Sciences, Inc., United States, (2) City of New York School of Medicine, United States
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News